NCT06893588View on ClinicalTrials.gov

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

February 14, 2027

Study Completion Date

March 15, 2027

Conditions
Cerebral VasospasmAneurysmal Subarachnoid Hemorrhage (aSAH)
Interventions
DEVICE

NEVA VS

cerebral artery dilation device

Sponsors

Lead Sponsor

Vesalio
All Listed Sponsors
lead

Vesalio

INDUSTRY

NCT06893588 - Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts | Biotech Hunter | Biotech Hunter